Terminated NA INTERVENTIONAL 2-arm NCT00308776

Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa

Effect of Cholecystokinin on Binge Eating in Bulimia Nervosa

Sponsor: National Institute of Mental Health (NIMH)

Conditions Bulimia Nervosa Eating Disorders

Interventions Cholecystokinin (CCK) infusion Saline infusion

Updated 5 times since 2017 Last updated: May 25, 2012 Started: Oct 31, 2003 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Unable to recruit subjects

Other terminated trials from National Institute of Mental Health (NIMH)

See all terminations from National Institute of Mental Health (NIMH)

A NA clinical study on Bulimia Nervosa and Eating Disorders, this trial is terminated or withdrawn. The trial is conducted by National Institute of Mental Health (NIMH) and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
New York State Psychiatric Institute

Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States